{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:01:17Z","timestamp":1791007277184,"version":"4.1.0"},"reference-count":186,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.preteyeres.2004.02.003","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T09:27:58Z","timestamp":1081934878000},"page":"253-281","source":"Crossref","is-referenced-by-count":172,"title":["Drug delivery systems for vitreoretinal diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"Tsutomu","family":"Yasukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2004.02.003_BIB1","first-page":"2554","article-title":"Enhanced FGF-2 movement through human sclera after exposure to latanoprost","volume":"42","author":"Aihara","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1350-9462(01)00018-0","article-title":"Transscleral drug delivery to the retina and choroid","volume":"21","author":"Ambati","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB3","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB4","first-page":"1186","article-title":"Transscleral delivery of bioactive protein to the choroid and retina","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","article-title":"Age-related macular degeneration","volume":"48","author":"Ambati","year":"2003","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB6","doi-asserted-by":"crossref","unstructured":"American Academy of Ophthalmology, 2000. Photodynamic therapy with verteporfin for age-related macular degeneration. Ophthalmology 107, 2314\u20132317.","DOI":"10.1016\/S0161-6420(00)00562-5"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000027378","article-title":"Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker","volume":"212","author":"Armstrong","year":"1998","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0161-6420(86)33780-1","article-title":"Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit","volume":"93","author":"Barza","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0039-6257(82)90080-7","article-title":"Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis, III","volume":"26","author":"Baum","year":"1982","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB11","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1016\/S0021-9258(18)68727-7","article-title":"Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance","volume":"263","author":"Beckman","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB12","first-page":"273","article-title":"Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice","volume":"48","author":"Bendich","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1350-9462(99)00014-2","article-title":"Intravitreal administration of antisense oligonucleotides","volume":"19","author":"Bochot","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archopht.1997.01100160241017","article-title":"Submacular surgery","volume":"115","author":"Bressler","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(94)90037-X","article-title":"Vascular targeting\u2014a new approach to the therapy of solid tumors","volume":"64","author":"Burrows","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB16","first-page":"1623","article-title":"Up-regulation of endoglin on vascular endothelial cells in human solid tumors","volume":"1","author":"Burrows","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-6420(89)32900-9","article-title":"Treatment of cytomegalovirus retinitis with intravitreal ganciclovir","volume":"96","author":"Cantrill","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00006982-199809000-00010","article-title":"Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis","volume":"18","author":"Canzano","year":"1998","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1083\/jcb.108.3.1139","article-title":"A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors","volume":"108","author":"Carnemolla","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB20","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1016\/S0959-8049(96)00388-7","article-title":"TNP-470 (AGM-1470)","volume":"32A","author":"Castronovo","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bjo.77.5.265","article-title":"Treatment of age-related subfoveal neovascular membranes by teletherapy","volume":"77","author":"Chakravarthy","year":"1993","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB22","first-page":"1523","article-title":"Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation","volume":"41","author":"Cheng","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/jop.1988.4.153","article-title":"Transscleral and transcorneal iontophoresis of vancomycin in rabbit eye","volume":"4","author":"Choi","year":"1988","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB24","first-page":"3543","article-title":"An improved apparatus for transscleral iontophoresis of gentamicin","volume":"33","author":"Church","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB25","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0161-6420(91)32135-3","article-title":"Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome","volume":"98","author":"Cocherau-Massin","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s004170050321","article-title":"Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit","volume":"237","author":"de Rojas Silva","year":"1999","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00001813-199206000-00001","article-title":"Drug\u2013polymer conjugates","volume":"3","author":"Duncan","year":"1992","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB28","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1084\/jem.174.5.1275","article-title":"Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors","volume":"174","author":"Dvorak","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s004170050239","article-title":"Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration","volume":"237","author":"Eckardt","year":"1999","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.85.4.461","article-title":"Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy","volume":"85","author":"El-Ghrably","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB31","first-page":"4154","article-title":"Phase I clinical comparative study of monoclonal antibody KS1\/4 and KS1\/4-methotrexate immunoconjugate in patients with non-small cell lung carcinoma","volume":"50","author":"Elias","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB32","first-page":"3183","article-title":"Limitation of radiolabeled monoclonal antibodies for localization of human neoplasms","volume":"46","author":"Epenetos","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB33","first-page":"59","article-title":"Angiogenesis research","volume":"9","author":"Folkman","year":"1999","journal-title":"Forum (Genova)"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB34","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","article-title":"Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases","volume":"93","author":"Friedlander","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/phrs.2000.0695","article-title":"Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin","volume":"42","author":"Fundaro","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB36","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archopht.119.8.1165","article-title":"Increased matrix metalloproteinases 1, 2 and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment","volume":"119","author":"Gaton","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB38","first-page":"2743","article-title":"Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR","volume":"34","author":"Giordano","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/02713689508995797","article-title":"Biodegradation and tissue reaction to intravitreous biodegradable poly(d,l-lactic-co-glycolic)acid microspheres","volume":"14","author":"Giordano","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB40","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0161-6420(95)30857-3","article-title":"Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy","volume":"102","author":"Gonzalez-Avila","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(90)32552-6","article-title":"Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome","volume":"97","author":"Gross","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0161-6420(89)32832-6","article-title":"Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye","volume":"96","author":"Grossman","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB43","first-page":"2678","article-title":"In vivo gene transfer into the retina mediated by a novel liposome system","volume":"37","author":"Hangai","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00915740","article-title":"Bioavailability of microsphere-entrapped cyclosporine A in the cornea and aqueous of rabbits","volume":"17","author":"Harper","year":"1993","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB45","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archopht.1994.01090220130035","article-title":"Scleral plug of biodegradable polymers for controlled drug release in the vitreous","volume":"112","author":"Hashizoe","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/02713689509003758","article-title":"Biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy","volume":"14","author":"Hashizoe","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1076\/ceyr.16.7.633.5063","article-title":"Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits","volume":"16","author":"Hashizoe","year":"1997","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB48","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/archopht.1989.01070020849025","article-title":"Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy","volume":"107","author":"Heinemann","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0161-6420(87)33454-2","article-title":"Cytomegalovirus retinitis and response to therapy with ganciclovir","volume":"94","author":"Henderly","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0039-6257(89)90103-3","article-title":"Cytomegalovirus retinitis","volume":"34","author":"Hennis","year":"1984","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","article-title":"Biodegradable microspheres for vitreoretinal drug delivery","volume":"52","author":"Herrero-Vanrell","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB52","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1023\/A:1026464124412","article-title":"Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process","volume":"17","author":"Herrero-Vanrell","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.eye.6700190","article-title":"Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy","volume":"16","author":"Hinton","year":"2002","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0161-6420(83)80009-8","article-title":"Acquired immune deficiency syndrome","volume":"90","author":"Holland","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB56","doi-asserted-by":"crossref","unstructured":"Holland, G.N., Sakamoto, M.J., Hardy, D., Sidikaro, Y., Kreiger, A.E., Frenkel, L.M., The UCLA CMV Retinopathy Study Group, 1986. Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxyl-1-(hydroxy-methyl)ethoxymethyl] guanine. Arch. Ophthalmol. 104, 1794\u20131800.","DOI":"10.1001\/archopht.1986.01050240068042"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB57","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1023\/A:1015948829632","article-title":"Release of human serum albumin from poly(lactide-co-glycolide) microspheres","volume":"7","author":"Hora","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB58","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.275.5299.547","article-title":"Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature","volume":"275","author":"Huang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB59","doi-asserted-by":"crossref","unstructured":"Hueber, A., Wiedemann, P., Esser, P., Heimann, K., 1996\u20131997. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Int. Ophthalmol. 20, 345\u2013350.","DOI":"10.1007\/BF00176889"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0002-9394(14)72131-2","article-title":"Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide","volume":"122","author":"Ip","year":"1996","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB61","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0161-6420(87)33535-3","article-title":"Treatment of cytomegalovirus retinitis with ganciclovir","volume":"94","author":"Jabs","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archopht.1989.01070010077031","article-title":"Cytomegalovirus retinitis and acquired immunodeficiency syndrome","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0161-6420(98)91176-9","article-title":"Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis","volume":"105","author":"Jaffe","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB64","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(00)00466-8","article-title":"Fluocinolone acetonide sustained drug delivery device to treat severe uveitis","volume":"107","author":"Jaffe","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB65","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00006982-200004000-00015","article-title":"Dexamethasone sustained drug delivery implant for the treatment of severe uveitis","volume":"20","author":"Jaffe","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB66","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0161-6420(89)32818-1","article-title":"Proliferative vitreoretinopathy membranes. An immunohistochemical study","volume":"96","author":"Jerdan","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB67","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy","volume":"84","author":"Jonas","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB68","first-page":"2664","article-title":"Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat","volume":"42","author":"Kamizuru","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB69","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archopht.1981.03930020319025","article-title":"Epiretinal and vitreous membranes. Comparative study of 56 cases","volume":"99","author":"Kampik","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.80.2.101","article-title":"Submacular surgery for choroidal neovascularization","volume":"80","author":"Kaplan","year":"1996","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB71","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/6509","article-title":"Fas ligand (CD95 ligand) controls angiogenesis beneath the retina","volume":"5","author":"Kaplan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/314639","article-title":"Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy","volume":"179","author":"Karavellas","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB73","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1073\/pnas.84.6.1487","article-title":"Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model","volume":"84","author":"Katre","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB74","first-page":"840","article-title":"Clearance of fluorescein incorporated into microspheres from the cornea and aqueous after subconjunctival injection","volume":"21","author":"Khoobehi","year":"1990","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB75","first-page":"175","article-title":"Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection","volume":"22","author":"Khoobehi","year":"1991","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB76","first-page":"1514","article-title":"Increased human scleral permeability with prostaglandin exposure","volume":"42","author":"Kim","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000050849","article-title":"Biodegradable polymers for ocular drug delivery","volume":"215","author":"Kimura","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB78","first-page":"3436","article-title":"Injectable microspheres with controlled drug release for glaucoma filtering surgery","volume":"33","author":"Kimura","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB79","first-page":"2815","article-title":"A new vitreal drug delivery system using an implantable biodegradable polymer device","volume":"35","author":"Kimura","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB80","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/02713689409167299","article-title":"In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release","volume":"13","author":"Kimura","year":"1994","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB81","first-page":"2110","article-title":"A new model of subretinal neovascularization in the rabbit","volume":"36","author":"Kimura","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB82","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","article-title":"Prevalence of age-related maculopathy","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB83","first-page":"1181","article-title":"E-selectin is present in proliferating endothelial cells in human hemangiomas","volume":"148","author":"Kraling","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB84","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2667::AID-CNCR44>3.0.CO;2-7","article-title":"Chimerization of Mu-9","volume":"80","author":"Krishnan","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0168-3659(95)00074-I","article-title":"Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits","volume":"37","author":"Kunou","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-3659(00)00267-4","article-title":"Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis","volume":"68","author":"Kunou","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB87","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bjc.1994.41","article-title":"Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)","volume":"69","author":"Kusaka","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB88","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9394(02)01536-2","article-title":"Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy","volume":"134","author":"La Heij","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB89","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archopht.1989.01070020438050","article-title":"Transscleral iontophoresis of dexamethasone","volume":"107","author":"Lam","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB90","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00170699","article-title":"A histopathologic study of retinal lesions inflicted by transscleral iontophoresis","volume":"229","author":"Lam","year":"1991","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB91","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/jop.1994.10.571","article-title":"Intravitreal delivery of ganciclovir in rabbits by transscleral iontophoresis","volume":"10","author":"Lam","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-409X(95)00012-V","article-title":"Ocular drug delivery","volume":"16","author":"Lang","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB93","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2003.10.012","article-title":"Incorporation and release behavior of hydrophobic drug in functionalized poly(d,l-lactide)-block-poly(ethylene oxide) micelles","volume":"94","author":"Lee","year":"2004","journal-title":"J. Control. Release."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB94","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9394(98)00443-7","article-title":"Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis","volume":"127","author":"Lim","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9394(75)90862-4","article-title":"Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation)","volume":"80","author":"Machemer","year":"1975","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB96","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group, 1986. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch. Ophthalmol. 104, 503\u2013512.","DOI":"10.1001\/archopht.1986.01050160059012"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB97","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group, 1990. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch. Ophthalmol. 108, 825\u2013831.","DOI":"10.1001\/archopht.1990.01070080067037"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB98","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group, 1994a. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch. Ophthalmol. 112, 480\u2013488.","DOI":"10.1001\/archopht.1994.01090160056023"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB99","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group, 1994b. Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials. Arch. Ophthalmol. 112, 500\u2013509.","DOI":"10.1001\/archopht.1994.01090160076025"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB100","first-page":"S233","article-title":"Results of the age-related macular degeneration and thalidomide study (AMDATS)","volume":"42","author":"Maguire","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB101","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0163-7827(02)00004-8","article-title":"A lipid based depot (DepoFoam technology) for sustained release drug delivery","volume":"41","author":"Mantripragada","year":"2002","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB102","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB103","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(86)33781-3","article-title":"Iontophoresis of fluorescein into the posterior segment of the rabbit eye","volume":"93","author":"Maurice","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB104","series-title":"Pharmacology of the Eye","first-page":"19","article-title":"Ocular pharmacokinetics","author":"Maurice","year":"1984"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1167\/iovs.02-0260","article-title":"P2Y receptor-mediated stimulation of Muller glial cell DNA synthesis","volume":"44","author":"Milenkovic","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB106","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bjo.83.6.652","article-title":"Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy","volume":"83","author":"Mitchell","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB107","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1167\/iovs.02-1210","article-title":"Noninvasive technique for monitoring chorioretinal temperature during transpupillary thermotherapy, with a thermosensitive liposome","volume":"44","author":"Miura","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB108","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1076\/ceyr.16.9.930.5042","article-title":"Biodegradable scleral implant for intravitreal controlled release of fluconazole","volume":"16","author":"Miyamoto","year":"1997","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB109","first-page":"1496","article-title":"Effect of focal X-ray irradiation on experimental choroidal neovascularization","volume":"40","author":"Miyamoto","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1248\/bpb.21.188","article-title":"Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(dl-lactic acid) implants","volume":"21","author":"Morita","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB111","first-page":"1785","article-title":"Microspheres of biodegradable polymers as a drug-delivery system in the vitreous","volume":"32","author":"Moritera","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB112","first-page":"3125","article-title":"Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy","volume":"33","author":"Moritera","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB113","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/02713689408995774","article-title":"Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres","volume":"13","author":"Moritera","year":"1994","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB114","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0161-6420(95)31010-X","article-title":"Replacing ganciclovir implants","volume":"102","author":"Morley","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Ganciclovir implant study group","volume":"335","author":"Musch","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB116","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/bc00014a007","article-title":"Preparation and properties of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate","volume":"3","author":"Noguchi","year":"1992","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB117","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1248\/cpb.36.2576","article-title":"In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic\/glycolic)acids and in vivo degradation of these polymers","volume":"36","author":"Ogawa","year":"1988","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB118","first-page":"1891","article-title":"The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes","volume":"40","author":"Oh","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB119","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1167\/iovs.02-0375","article-title":"Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate","volume":"44","author":"Okabe","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB120","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1167\/iovs.02-0956","article-title":"Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device","volume":"44","author":"Okabe","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB121","first-page":"1893","article-title":"Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning","volume":"36","author":"Olsen","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB122","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/bjc.1996.227","article-title":"Effects of neocarzinostatin-chimeric Fab conjugates on the growth of human pancreatic carcinoma xenografts","volume":"73","author":"Otsuji","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB123","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0161-6420(84)34201-4","article-title":"Ophthalmic involvement in acquired immunodeficiency syndrome","volume":"91","author":"Palestine","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB124","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.97.1.75","article-title":"Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice","volume":"97","author":"Patel","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB125","first-page":"465","article-title":"Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses","volume":"148","author":"Patey","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-200241070-00003","article-title":"Clinical pharmacokinetics of depot leuprorelin","volume":"41","author":"Periti","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB127","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0002-9394(02)01641-0","article-title":"Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization","volume":"134","author":"Pertile","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00006982-198707040-00005","article-title":"Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model","volume":"7","author":"Peyman","year":"1987","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00130002","article-title":"Intravitreal liposome-encapsulated drugs","volume":"12","author":"Peyman","year":"1988","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB130","doi-asserted-by":"crossref","unstructured":"Pharmacologic Therapy for Macular Degeneration Study Group, 1997. Interferon Alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration: results of a prospective randomized placebo-controlled clinical trial. Arch. Ophthalmol. 115, 865\u2013872.","DOI":"10.1001\/archopht.1997.01100160035005"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB131","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/jps.2600681219","article-title":"Sustained drug delivery systems. II. Factors affecting release rates from poly(e-caprolactone) and related biodegradable polymers","volume":"68","author":"Pitt","year":"1979","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB132","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/art.1780340504","article-title":"Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration","volume":"34","author":"Reiter","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB133","doi-asserted-by":"crossref","unstructured":"Retinal Society Terminology Committee, 1983. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90, 121\u2013125.","DOI":"10.1016\/S0161-6420(83)34588-7"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB134","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1073\/pnas.89.22.10832","article-title":"Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer","volume":"89","author":"Rettig","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archopht.1994.01090150137036","article-title":"Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil","volume":"112","author":"Rubsamen","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB136","series-title":"Retina","first-page":"1027","article-title":"Subretinal neovascularization","author":"Ryan","year":"1994"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB137","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000055638","article-title":"Effect of particle size of polymeric nanospheres on intravitreal kinetics","volume":"33","author":"Sakurai","year":"2001","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB138","first-page":"2043","article-title":"Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis","volume":"42","author":"Sakurai","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB139","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1167\/iovs.02-1246","article-title":"Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB140","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB141","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1167\/iovs.02-1228","article-title":"Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB142","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archopht.1992.01080140044023","article-title":"Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis","volume":"110","author":"Sanborn","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB143","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/jps.2600730927","article-title":"Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres","volume":"73","author":"Sanders","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB144","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/jop.1994.10.69","article-title":"The role of iontophoresis in ocular drug delivery","volume":"10","author":"Sarraf","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB145","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0002-9394(14)73642-6","article-title":"Transscleral iontophoresis of foscarnet","volume":"115","author":"Sarraf","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB146","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0360-3016(97)00296-4","article-title":"Radiation therapy for ocular choroidal neovascularization (phage I\/II study)","volume":"39","author":"Sasai","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB147","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02172967","article-title":"Proteins of the extracellular matrix in vitreoretinal membranes","volume":"226","author":"Scheiffarth","year":"1988","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB148","first-page":"690","article-title":"Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma","volume":"62","author":"Schlingemann","year":"1990","journal-title":"Lab. Invest."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB149","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.eye.6700299","article-title":"Vitreous surgery in the management of chronic endogenous posterior uveitis","volume":"17","author":"Scott","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB150","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/bjo.82.9.1063","article-title":"Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularization in the rat","volume":"82","author":"Shen","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB151","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archopht.1992.01080140111037","article-title":"Intravitreal sustained-release ganciclovir","volume":"110","author":"Smith","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB152","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jama.277.8.614","article-title":"The art of \u2018HAART\u2019","volume":"277","author":"Stephenson","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB153","first-page":"25","article-title":"Potentiated in vivo biological activity of basic fibroblast growth factor by incorporation into polymer hydrogel microspheres","volume":"4","author":"Tabata","year":"1995","journal-title":"Proc. 4th Jpn. Int. SAMPE. Symp."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB154","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0169-409X(97)00125-7","article-title":"Protein release from gelatin matrices","volume":"31","author":"Tabata","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10717549709051895","article-title":"Electric charge influence of dextran derivatives on their tumor accumulation after intravenous injection","volume":"4","author":"Tabata","year":"1997","journal-title":"Drug Deliv."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB156","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-3659(97)00129-6","article-title":"Tumor accumulation of poly(vinyl alcohol) of different sizes after intravenous injection","volume":"50","author":"Tabata","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB157","first-page":"101","article-title":"Chemical conjugation of interferon with pullulan and its antiviral activity","volume":"9","author":"Tabata","year":"1999","journal-title":"S. T. P. Pharma. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB158","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(98)00190-4","article-title":"Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination","volume":"59","author":"Tabata","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB159","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/107999099314225","article-title":"Simple mixing of IFN with a polysaccharide having high liver affinity enables IFN to target to the liver","volume":"19","author":"Tabata","year":"1999","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1096\/fasebj.11.1.9034166","article-title":"Growth factors in the extracellular matrix","volume":"11","author":"Taipale","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB161","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archopht.118.1.78","article-title":"Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization","volume":"118","author":"Tolentino","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB162","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0161-6420(88)33147-7","article-title":"Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis","volume":"95","author":"Ussery","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB163","first-page":"665","article-title":"Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus","volume":"38","author":"Veloso","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB164","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.2042-7158.1983.tb02888.x","article-title":"Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters","volume":"35","author":"Veronese","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB165","first-page":"14","article-title":"Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes","volume":"31","author":"Vinores","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB166","first-page":"3299","article-title":"Ocular aspirin distribution","volume":"43","author":"Voigt","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB167","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0161-6420(98)97031-2","article-title":"Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts","volume":"105","author":"Vrabec","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB168","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jps.2600791016","article-title":"Lactic acid oligomer microspheres containing hydrophilic drugs","volume":"79","author":"Wada","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB169","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1076\/ceyr.18.3.203.5368","article-title":"Expression of vascular endothelial growth factor and its receptor (KDR\/flk-1) mRNA in experimental choroidal neovascularization","volume":"18","author":"Wada","year":"1999","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB170","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1023\/A:1016037225728","article-title":"Liver targeting of interferon through pullulan conjugation","volume":"13","author":"Xi","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB171","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.2042-7158.1995.tb05835.x","article-title":"Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration","volume":"47","author":"Yamaoka","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB172","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/01932690208984204","article-title":"A comparison of membrane emulsification obtained using SPG (Shirasu Porous Glass) and PTFE [poly(tetrafluoroethylene)] membranes","volume":"23","author":"Yamazaki","year":"2002","journal-title":"J. Disper. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB173","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.116.1.69","article-title":"An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy","volume":"116","author":"Yang","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB174","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000055582","article-title":"Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel","volume":"32","author":"Yang","year":"2000","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB175","first-page":"2690","article-title":"Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization","volume":"40","author":"Yasukawa","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB176","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s004170050031","article-title":"Biodegradable scleral implant for intravitreal controlled release of ganciclovir","volume":"238","author":"Yasukawa","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB177","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1076\/ceyr.21.6.952.6992","article-title":"Active drug targeting with immunoconjugates to choroidal neovascularization","volume":"21","author":"Yasukawa","year":"2000","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB178","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-409X(01)00192-2","article-title":"Biodegradable scleral plugs for vitreoretinal drug delivery","volume":"52","author":"Yasukawa","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB179","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00417-002-0484-9","article-title":"Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits","volume":"240","author":"Yasukawa","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB180","first-page":"842","article-title":"Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination","volume":"43","author":"Yasukawa","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB181","first-page":"S2805","article-title":"A new model of age-related macular degeneration induced by advanced glycation end products","volume":"43","author":"Yasukawa","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB182","first-page":"S1698","article-title":"Possible role of advanced glycoxidation products accumulated in retinal pigment epithelial cells in the pathology of age-related maculopathy","volume":"44","author":"Yasukawa","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB183","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/jop.1991.7.163","article-title":"Experimental transscleral iontophoresis of ciprofloxacin","volume":"7","author":"Yoshizumi","year":"1991","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB184","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/jop.1995.11.183","article-title":"Ocular toxicity of iontophoretic foscarnet in rabbits","volume":"11","author":"Yoshizumi","year":"1995","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/jop.1997.13.529","article-title":"Determination of ocular toxicity in multiple applications of foscarnet iontophoresis","volume":"13","author":"Yoshizumi","year":"1997","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2004.02.003_BIB186","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(98)00061-3","article-title":"Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy","volume":"55","author":"Zhou","year":"1998","journal-title":"J. Control. Release"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946204000138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946204000138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T15:47:32Z","timestamp":1623772052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946204000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":186,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S1350946204000138"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2004.02.003","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}